As of 2025-07-20, the Relative Valuation of Castle Biosciences Inc (CSTL) is 5.74 USD. This relative valuation is based on P/E multiples. With the latest stock price at 16.54 USD, the upside of Castle Biosciences Inc based on Relative Valuation is -65.3%.
The range of the Relative Valuation is (5.23) - 17.29 USD.
| Range | Selected | |
| Trailing P/E multiples | 29.8x - 31.9x | 30.8x |
| Forward P/E multiples | 16.5x - 17.3x | 16.9x |
| Fair Price | (5.23) - 17.29 | 5.74 |
| Upside | -131.6% - 4.5% | -65.3% |
| Date | P/E |
| 2025-07-17 | -99.04 |
| 2025-07-16 | -106.39 |
| 2025-07-15 | -107.47 |
| 2025-07-14 | -111.06 |
| 2025-07-11 | -111.97 |
| 2025-07-10 | -113.00 |
| 2025-07-09 | -114.59 |
| 2025-07-08 | -112.54 |
| 2025-07-07 | -110.83 |
| 2025-07-03 | -115.62 |
| 2025-07-02 | -113.97 |
| 2025-07-01 | -115.84 |
| 2025-06-30 | -116.30 |
| 2025-06-27 | -115.90 |
| 2025-06-26 | -112.48 |
| 2025-06-25 | -110.89 |
| 2025-06-24 | -109.12 |
| 2025-06-23 | -107.36 |
| 2025-06-20 | -105.48 |
| 2025-06-18 | -107.70 |
| 2025-06-17 | -105.59 |
| 2025-06-16 | -109.75 |
| 2025-06-13 | -106.79 |
| 2025-06-12 | -107.19 |
| 2025-06-11 | -105.02 |
| 2025-06-10 | -102.75 |
| 2025-06-09 | -103.49 |
| 2025-06-06 | -100.24 |
| 2025-06-05 | -96.94 |
| 2025-06-04 | -96.94 |
| 2025-06-03 | -95.17 |
| 2025-06-02 | -92.66 |
| 2025-05-30 | -90.96 |
| 2025-05-29 | -90.84 |
| 2025-05-28 | -92.44 |
| 2025-05-27 | -89.99 |
| 2025-05-23 | -91.70 |
| 2025-05-22 | -90.50 |
| 2025-05-21 | -91.24 |
| 2025-05-20 | -93.97 |
| 2025-05-19 | -93.40 |
| 2025-05-16 | -95.40 |
| 2025-05-15 | -93.86 |
| 2025-05-14 | -92.95 |
| 2025-05-13 | -96.99 |
| 2025-05-12 | -97.05 |
| 2025-05-09 | -95.60 |
| 2025-05-08 | -98.02 |
| 2025-05-07 | -97.11 |
| 2025-05-06 | -94.66 |